Annual Milestone Reports. Annually, by November 1st of each calendar year during the Term, Company shall provide CyDex with written reports that: describe in reasonable detail Company’s progress made toward achievement of the milestones specified in Section 4.1(b) above during [***]; and set forth such other information regarding Captisol as mutually agreed upon by the parties. Company shall also provide quarterly updates regarding any significant changes to the expected completion of any such milestones outlined in the annual report or any change that may materially affect the Supply Agreement or orders placed thereunder.
Appears in 2 contracts
Samples: License Agreement (Ligand Pharmaceuticals Inc), License Agreement (Ligand Pharmaceuticals Inc)
Annual Milestone Reports. Annually, by By November 1st of each calendar year during the Term, Company shall provide CyDex with written reports that: that describe in reasonable detail Company’s progress made toward achievement of the milestones specified in Section 4.1(b) above during [***]; such calendar year and set forth such other information regarding Licensed Products and/or Captisol as mutually agreed upon by the parties. Company shall also provide quarterly updates regarding any to the extent that significant changes to the expected completion of any such milestones outlined in the annual report or any change that may materially affect the Supply Agreement or orders placed thereunderhave occurred.
Appears in 2 contracts
Samples: License Agreement (Ligand Pharmaceuticals Inc), License Agreement (Ligand Pharmaceuticals Inc)
Annual Milestone Reports. Annually, by By November 1st of each calendar year during the Term, Company shall provide CyDex with written reports that: that describe in reasonable detail Company’s progress made toward achievement of the milestones specified in Section 4.1(b) above during [***]; such calendar year and set forth such other information regarding Captisol as mutually agreed upon by the parties. Company shall also provide quarterly updates regarding any significant changes to the expected completion of any such milestones outlined in the annual report or any change that may materially affect the Supply Agreement or orders placed thereunderreport.
Appears in 1 contract
Samples: License Agreement (MEI Pharma, Inc.)
Annual Milestone Reports. Annually, by November 1st of each calendar year By [***] during the Term, Company shall provide CyDex with written reports that: that describe in reasonable detail Company’s progress made toward achievement of the milestones specified in Section 4.1(b) above during such [***]; ] and set forth such other information regarding Captisol as mutually agreed upon by the parties. Company shall also provide quarterly updates [***] regarding any significant changes to the expected completion of any such milestones outlined in the annual report [***] or any change that may materially affect the Supply Agreement or orders placed thereunder.
Appears in 1 contract